IRIS
ROSSI, LUIGIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 11.707
EU - Europa 7.388
AS - Asia 3.228
OC - Oceania 32
AF - Africa 22
Continente sconosciuto - Info sul continente non disponibili 17
SA - Sud America 13
Totale 22.407
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 11.663
GB - Regno Unito 3.038
CN - Cina 2.100
UA - Ucraina 1.262
IT - Italia 868
SE - Svezia 722
FI - Finlandia 462
TR - Turchia 451
DE - Germania 383
SG - Singapore 347
IE - Irlanda 280
RU - Federazione Russa 180
JP - Giappone 113
KR - Corea 60
FR - Francia 57
IN - India 54
CA - Canada 37
AU - Australia 30
BE - Belgio 27
PK - Pakistan 22
HK - Hong Kong 18
PL - Polonia 17
ES - Italia 16
EU - Europa 14
RO - Romania 14
IR - Iran 13
NL - Olanda 13
TG - Togo 12
AT - Austria 10
VN - Vietnam 8
KZ - Kazakistan 6
SA - Arabia Saudita 6
BR - Brasile 5
CH - Svizzera 5
CZ - Repubblica Ceca 4
NO - Norvegia 4
PT - Portogallo 4
ZA - Sudafrica 4
A2 - ???statistics.table.value.countryCode.A2??? 3
AE - Emirati Arabi Uniti 3
AZ - Azerbaigian 3
CL - Cile 3
DK - Danimarca 3
ID - Indonesia 3
LK - Sri Lanka 3
MA - Marocco 3
MX - Messico 3
TW - Taiwan 3
AM - Armenia 2
BD - Bangladesh 2
BG - Bulgaria 2
EC - Ecuador 2
GR - Grecia 2
KH - Cambogia 2
LA - Repubblica Popolare Democratica del Laos 2
LT - Lituania 2
NG - Nigeria 2
NZ - Nuova Zelanda 2
PA - Panama 2
PE - Perù 2
RS - Serbia 2
SI - Slovenia 2
SM - San Marino 2
TH - Thailandia 2
BY - Bielorussia 1
CO - Colombia 1
CR - Costa Rica 1
CY - Cipro 1
EE - Estonia 1
EG - Egitto 1
GE - Georgia 1
HR - Croazia 1
HU - Ungheria 1
IL - Israele 1
JM - Giamaica 1
JO - Giordania 1
LU - Lussemburgo 1
MD - Moldavia 1
MK - Macedonia 1
PH - Filippine 1
Totale 22.407
Salva come PNG Salva come JPEG
Città #
Southend 2.825
Fairfield 1.692
Woodbridge 1.548
Houston 1.074
Jacksonville 1.010
Ann Arbor 892
Chandler 741
Ashburn 711
Cambridge 653
Seattle 642
Wilmington 578
Nanjing 541
Izmir 348
Dublin 278
Singapore 270
Boardman 266
Nanchang 229
Urbino 216
Helsinki 193
San Mateo 167
Beijing 155
Princeton 150
Shenyang 124
Hebei 120
New York 110
Jiaxing 101
Tianjin 92
Changsha 83
Düsseldorf 68
Istanbul 68
Kunming 61
San Diego 61
Mülheim 57
Bremen 55
Seongnam 50
Jinan 48
Shanghai 44
Guangzhou 41
Moscow 41
San Francisco 40
Munich 37
Zhengzhou 37
London 36
Santa Clara 34
Los Angeles 33
Hangzhou 32
Velikiy Novgorod 31
Ningbo 27
Toronto 27
Brussels 26
Changchun 23
Taizhou 21
Des Moines 19
Bologna 18
Rome 18
Auburn Hills 17
Fano 16
Redwood City 16
Leawood 14
Rawalpindi 14
Alexandria 12
Augusta 12
Kraków 12
Lanzhou 12
Lomé 12
Norwalk 12
Canberra 11
Haikou 10
Melbourne 10
Shenzhen 10
Wuppertal 10
Hong Kong 9
Seoul 9
Venice 9
Ancona 8
Dong Ket 8
Frankfurt am Main 8
Macerata 8
Pesaro 8
Senigallia 8
Copparo 7
Islington 7
Orange 7
Montemarciano 6
Portland 6
Rimini 6
Riyadh 6
Vienna 6
Alatri 5
Amsterdam 5
Astana 5
Cava De' Tirreni 5
Centro 5
Chiswick 5
Florence 5
Lahore 5
Mangalore 5
Osimo 5
Rockville 5
Stockholm 5
Totale 17.248
Salva come PNG Salva come JPEG
Nome #
Reengineering red blood cells for cellular therapeutics and diagnostics 285
A new therapy prevents intellectual disability in mouse with phenylketonuria 222
Label-free quantification of Tacrolimus in biological samples by atomic force microscopy 216
Engineering erythrocytes for the modulation of drugs' and contrasting agents' pharmacokinetics and biodistribution 216
Ex vivo encapsulation of dexamethasone sodium phosphate into human autologous erythrocytes using fully automated biomedical equipment 216
Pharmacokinetic and antiretroviral activity in mice of oral [P(1),P(2)-bis[2-(adenin-9-yl)ethoxymethyl]phosphonate], a prodrug of 9-(2-phosphonylmethoxyethyl)adenine 211
Red Blood Cell-Based Delivery of Drugs and Nanomaterials for Therapeutic and Diagnostic Applications 210
Inhibition of murine AIDS by combination of AZT and dideoxycytidine 5'-triphosphate 207
Cytotoxic activity of 2-Fluoro-ara-AMP and 2-Fluoro-ara-AMP-loaded erythrocytes against human breast carcinoma cell lines. 207
A NONLINEAR THREE-COMPARTMENT MODEL FOR THE ADMINISTRATION OF 2’, 3’- DIDEOXYCYTIDINE BY USING RED BLOOD CELLS AS BIOREACTORS 207
Inhibition of murine AIDS by a heterodinucleotide of azidothymidine and 9-(R)-2-(phosphonomethoxypropyl)adenine 205
Dexamethasone improves redox state in ataxia telangiectasia cells by promoting an NRF2-mediated antioxidant response 205
In vivo effects of dexamethasone on blood gene expression in ataxia telangiectasia 201
Human red blood cells as bioreactors for the release of 2', 3'-dideoxycytidine, an inhibitor of HIV infectivity. 200
Macrophage Depletion by Free Bisphosphonates and Zoledronate-Loaded Red Blood Cells 200
Erythrocyte-based drug delivery 199
Effect of macrophage depletion on viral DNA rebound following antiretroviral therapy in a murine model of AIDS (MAIDS) 198
null 197
Drug delivery through phagocytosis of red blood cells 196
Erythrocytes as a controlled drug delivery system: clinical evidences 195
Ultrastructural analysis of pancreatic acinar cells from mice fed on genetically modified soybean 193
Improved cellular uptake of functionalized single-walled carbon nanotubes 193
2',3'-Dideoxycytidine metabolism in a new drug-resistant cell line 193
2',3'-Dideoxycytidine induced drug resistance in human cells 191
Inhibition of murine AIDS by reduced glutathione. 190
Inhibition of HIV-1 replication in macrophages by red blood cell-mediated delivery of a heterodinucleotide of lamivudine and tenofovir 190
Red blood cells as advanced drug delivery systems for antiviral nucleoside analogues 189
Prolonged islet allograft survival in diabetic mice upon macrophage depletion by clodronate-loaded erythrocytes 186
Inhibition of HIV-1 replication in macrophages by a heterodinucleotide of lamivudine and tenofovir 186
Erythrocyte-mediated delivery of phenylalanine ammonia lyase for the treatment of phenylketonuria in BTBR-Pahenu2 mice 186
Acetaldehyde, ethanol and acetone concentrations in blood of alcohol-treated mice receiving aldehyde dehydrogenase-loaded erythrocytes 181
ATM splicing variants as biomarkers for low dose dexamethasone treatment of A-T 180
Drug delivery by red blood cells 179
A new acyclic heterodinucleotide active against human immunodeficiency virus and herpes simplex virus 177
Targeting antiviral nucleotide analogues to macrophages 175
Targeting nucleotide dimers containing antiviral nucleosides 174
Acyclovir prodrug and its use in pharmaceutical compositions 173
Approaches to erythrocyte-mediated drug delivery 173
Acetaldehyde dehydrogenase-loaded erythrocytes as bioreactors for the removal of blood acetaldehyde 172
Use of nonvolatile buffers in liquid chromatography/mass spectrometry: advantages of capillary-scale particle beam interfacing 172
Adherence and intracellular survival within human macrophages of Enterococcus faecalis isolates from coastal marine sediment 172
Drug delivery systems 170
Erythrocyte-mediated delivery of recombinant enzymes 170
Observation of erythrocyte dynamics in the retinal capillaries and choriocapillaris using ICG-loaded erythrocyte ghost cells 169
In vivo accelerated acetaldehyde metabolism using acetaldehyde dehydrogenase-loaded erythrocytes 169
Macrophage protection by nucleoside and nucleotide analogue administration 169
Erythrocyte-mediated delivery of dexamethasone in patients with mild-to-moderate ulcerative colitis, refractory to mesalamine: a randomized, controlled study 169
Role and mechanism of hexokinase decay during reticulocyte maturation and cell aging 169
Red Blood Cell Membrane Processing for Biomedical Applications 169
REVERSED-PHASE LIQUID CHROMATOGRAPHIC DETERMINATION OF 2’, 3’-DIDEOXYCYTIDINE IN HUMAN BLOOD SAMPLES 168
Human red blood cells as bioreactors for the release of 2',3'-dideoxycytidine, an inhibitor of HIV infectivity. 167
Activation of NRF2 by dexamethasone in ataxia telangiectasia cells involves KEAP1 inhibition but not the inhibition of p38 167
Human red blood cells as bioreactors for the release of 2',3'-dideoxycytidine, an inhibitor of HIV infectivity 164
Membrane-bound immunoglobulins increase during red blood cell aging. 164
Fine distribution of CLOCK protein in hepatocytes of hibernating dormice. 164
null 164
Normalization of hyperglycemia in diabetic mice by enzyme-loaded erythrocytes 163
Inhibition of murine AIDS by combination of AZT and DDCTP-loaded erythrocytes 163
In vivo accelerated acetaldehyde metabolism using acetaldehyde dehydrogenase-loaded erythrocytes. 160
Effect of age on some properties of mice erythrocytes 159
Acetaldehyde oxidation by aldehyde dehydrogenase-loaded erythrocytes. 158
Efficacy and toxicity of long-term administration of 2',3'-dideoxycytidine in the LP-BM5 murine-induced immunodeficiency model 158
FIV infection of macrophages: in vitro and in vivo inhibition by dideoxycytidine-5'-triphosphate. 156
Effect of listeriolysin O-loaded erythrocytes on Mycobacterium avium replication within macrophages 156
Effect of phenylhydrazine on red blood cell metabolism. 155
Erythrocyte-mediated delivery of drugs, peptides and modified oligonucleotides 154
2',3'- Dideoxycytidine permeation of the human erythrocyte membrane. 154
Synthesis and biological application of a new heterodinucleotide with both anti-HSV and anti-HIV activity 152
Metabolism, mitochondrial uptake and toxicity of 2’,3’-dideoxycytidine 151
Improved metabolic properties of hexokinase-overloaded human erythrocytes 149
Erythrocytes-mediated delivery of Dexamethasone in steroid-dependent IBD patients – A pilot uncontrolled study 149
Transformed erythrocytes, process for preparing the same, and their use in pharmaceutical compositions” PCT/EP 92/01291 149
An ex-vivo erythrocyte model for investigating oxidative metabolism 149
Inhibition of HIV-1 and LP-BM5 replication in macrophages by dideoxycytidine and dideoxycytidine 5'-triphosphate 148
Macrophage protection against human immunodeficiency virus or herpes simplex virus by red blood cell-mediated delivery of a heterodinucleotide of azidothymidine and acyclovir 148
Inhibition of murine retrovirus induced immunodeficiency by nucleoside analogues and combination therapy. 147
"Transformed erythrocytes, process for preparing the same, and their use in pharmaceutical compositions" 146
Macrophage protection by nucleoside and nucleotide analogue administration 146
Synthesis, caracterization and erythrocyte encapsulation of an azidothymidine homodinucleotide 144
Preparation of glutathione derivatives as antiviral agents 144
Red Blood Cell Loading: a Selection of Procedures 143
Phagocytosis reduces HIV-1 production in human monocytes/macrophages infected in vitro. 141
Erythrocyte-mediated delivery of a new homodinucleotide active against human immunodeficiency virus and herpes simplex virus 141
Role of hexokinase in the regulation of erythrocyte hexose monophosphate pathway under oxidative stress 141
EFFECT OF PHENYLHYDRAZINE ON RED BLOOD CELL METABOLISM. 141
Red blood cell phagocytosis following hexokinase inactivation. 140
Heterodimer-loaded erythrocytes as bioreactors for slow delivery of the antiviral drug azidothymidine and the antimycobacterial drug ethambutol 139
ALCUNE PROPRIETÀ DI GLOBULI ROSSI UMANI SOTTOPOSTI A DIALISI IPOTONICA E RISIGILLAMENTO DA UTILIZZARE COME VEICOLI O BIOREATTORI. 139
Targeting antiviral nucleotide analogues to macrophages 139
Erythrocytes as carriers of reduced glutathione (GSH) in the treatment of retroviral infections 139
Red blood cells as carriers of drugs against retroviruses 138
Macrophage uptake of SWNT-COOC18H37 derivatives coated by phosphatidylethanolamine or phosphatidylserine 137
Effect of antiviral treatments on the bone marrow in murine AIDS 137
In vitro and in vivo toxicity of 2',3'-dideoxycytidine in mice 136
Red blood cells as an antigen-delivery system. 135
Preclinical evaluation of an innovative anti-TAM approach based on zoledronate-loaded erythrocytes 135
Inhibition of HIV-1 replication in macrophages by red blood cell-mediated delivery of a heterodinucleotide of azidothymidine and 9-(R)-2-(phosphonomethoxypropyl)adenine 134
New synthetic glutathione derivatives with increased antiviral activities 132
Macrophage depletion by Clodronate-loaded erythrocytes 132
Low doses of dexamethasone constantly delivered by autologous erythrocytes slow the progression of lung disease in cystic fibrosis patients 132
Totale 16.939
Salva come PNG Salva come JPEG
Categoria #
all - tutte 75.580
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 75.580
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.003 0 0 0 0 0 360 412 361 275 270 153 172
2020/20212.854 97 241 184 307 249 230 184 226 355 242 389 150
2021/20221.667 140 130 171 219 69 59 66 95 124 119 32 443
2022/20232.462 301 107 40 244 247 530 7 177 435 122 161 91
2023/2024699 77 74 47 89 56 143 21 26 8 87 7 64
2024/20251.315 137 134 595 184 81 184 0 0 0 0 0 0
Totale 22.694